ARNI (ARNI) Stock Price & Analysis
ARNI (ARNI) rose 0.00% to USD 0 as of June 10, 2026 at 08:10 UTC, according to Nexqual real-time market data.
ARNI last closed at USD 0; the session ranged USD 0–0 on volume of 800 shares. Market capitalization is $9,869, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 08:10 UTC.
Key Statistics (as of June 10, 2026 at 08:10 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 800 shares |
| Market Cap | $9,869 |
| Exchange | PNK |
Technical Analysis (ARNI)
Nexqual's technical model rates ARNI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 08:10 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (ARNI)
Wall Street analysts rate ARNI "None", per Nexqual as of June 10, 2026 at 08:10 UTC.
| Consensus Rating | None |
|---|
Earnings (ARNI)
Source: Nexqual, June 10, 2026 at 08:10 UTC.
Financials & Fundamentals (ARNI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 1.52 |
| Total Cash | $2.12M |
| Total Debt | $5,088 |
| Free Cash Flow | $-3.95M |
Source: Nexqual, June 10, 2026 at 08:10 UTC.
Financial Health Score (ARNI)
Nexqual rates ARNI's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 08:10 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $2M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$8M |
| Efficiency | Mixed — No data |
Ownership (ARNI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +2.68% |
| Shares Outstanding | 49.35M |
| Float | 15.03M |
Source: Nexqual, June 10, 2026 at 08:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FPMI | FLUOROPHARMA MEDICAL INC | USD 0 | ▲ 0% |
| AOLS | AEOLUS PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| BZYR | Burzynski Research Institute, I | USD 0.01 | ▲ 0% |
| OVIT | ONCOVISTA INNOVATIVE THERAPIES | USD 0 | ▲ 0% |
| AMBS | Amarantus Bioscience Holdings, | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:10 UTC. This page is informational and not investment advice.